EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Methods for assessment of the tumour microenvironment and immune interactions in non-small cell lung cancer. A narrative review

Kanishka Rangamuwa, Christian Aloe, Michael Christie, Marie-Liesse Asselin-Labat, Daniel Batey, Lou Irving, Thomas John, Steven Bozinovski, Tracy L Leong, Daniel Steinfort

Frontiers in Oncology · 18.04.2023 · 13

DOI: 10.3389/fonc.2023.1129195 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Oncology, online erschienen am 18.04.2023. Verfasst von Kanishka Rangamuwa und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Royal Melbourne Hospital, Melbourne, VIC, Australia. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-small cell lung cancer (NSCLC) is one of the leading causes of cancer death worldwide. Immunotherapy with immune checkpoint inhibitors (ICI) has significantly improved outcomes in some patients, however 80-85% of patients receiving immunotherapy develop primary resistance, manifesting as a lack of response to therapy. Of those that do have an initial response, disease progression may occur due to acquired resistance. The make-up of the tumour microenvironment (TME) and the interaction between tumour infiltrating immune cells and cancer cells can have a large impact on the response to immunotherapy. Robust assessment of the TME with accurate and reproducible methods is vital to understanding mechanisms of immunotherapy resistance. In this paper we will review the evidence of several methodologies to assess the TME, including multiplex immunohistochemistry, imaging mass cytometry, flow cytometry, mass cytometry and RNA sequencing.

Schlagwörter

Stichwörter der Autor:innen

RNAseq analysiscytometryimmune interactionimmunohistochemistryimmunotherapynon-smal cell lung cancertumour microenvironment

Autor:innen und Institutionen

  • Department of Respiratory Medicine, Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Department of Medicine Royal Melbourne Hospital (RMH), University of Melbourne, Parkville, VIC, Australia.
  • School of Health and Biomedical Sciences, RMIT University, Bundoora, VIC, Australia.
  • Department of Pathology, Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Personalised Oncology Division, Walter Eliza Hall Institute, Melbourne, VIC, Australia.
  • Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.

Zitieren

APA

Rangamuwa, K., Aloe, C., Christie, M., Asselin-Labat, M. L., Batey, D., Irving, L., John, T., Bozinovski, S., Leong, T. L., & Steinfort, D. (2023). Methods for assessment of the tumour microenvironment and immune interactions in non-small cell lung cancer. A narrative review. Frontiers in Oncology, 13. https://doi.org/10.3389/fonc.2023.1129195

Vancouver

Rangamuwa K, Aloe C, Christie M, Asselin-Labat ML, Batey D, Irving L, et al. Methods for assessment of the tumour microenvironment and immune interactions in non-small cell lung cancer. A narrative review. Frontiers in Oncology. 2023;13. doi:10.3389/fonc.2023.1129195

BibTeX
@article{Rangamuwa2023,
  author = {Rangamuwa, Kanishka and Aloe, Christian and Christie, Michael and Asselin-Labat, Marie-Liesse and Batey, Daniel and Irving, Lou and John, Thomas and Bozinovski, Steven and Leong, Tracy L and Steinfort, Daniel},
  title = {Methods for assessment of the tumour microenvironment and immune interactions in non-small cell lung cancer. A narrative review},
  journal = {Frontiers in Oncology},
  year = {2023},
  volume = {13},
  doi = {10.3389/fonc.2023.1129195}
}
Kostenlos starten →